Learn more about whether Amicus Therapeutics, Inc. or Merus N.V. is a better investment based on AAII's A+ Investor grades, ...

Roivant Sciences posted earnings that exceeded expectations, with substantial progress in its diversified drug pipeline.

Guggenheim maintained a Buy rating on Neurocrine Biosciences (NASDAQ:NBIX) but lowered the price target to $163 from $165. The adjustment follows the company's fourth-quarter sales report, which ...

Loews Corp (NYSE:L) reported a fourth-quarter revenue of $4.55 billion compared to $4.26 billion a year ago. EPS was $0.86, ...

Some think investing in stocks requires substantial start-up capital, but that's false. Even with a modest sum, like $40, investors can acquire shares of companies whose long-term prospects look ...

We recently compiled a list of the 13 Best Natural Gas and Oil Dividend Stocks To Buy. In this article, we are going to take ...

Norwegian major estimates volume of Russian pipeline gas that would return to Europe if Ukraine conflict were to end would be ...

TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China sales ...

Axsome's CEO, Herriot Tabuteau, MD, expressed pride in the company's commitment to improving patient outcomes and emphasized ...

Shares are on their best run since October, with investors hopeful they'll finally get some clarity on the company's ...

Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, which is ...

KRN Heat Exchanger has seen a 150% stock surge since its debut, driven by strong demand and expansion plans. With a 6X ...